Manufacturer record
Mediwell Biotech: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Mediwell Biotech (Himachal Pradesh) were declared Not of Standard Quality between August 2022 and October 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Mediwell Biotech in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amoxycillin and Potassium Clavulanate Tablets IP (Moxileb-CV 625 Tablets) | MBT23068Mfg 2023-10 · Exp 2025-09 | Assay of Amoxycillin Trihydrate calculated as AmoxycillinAssay | RDTL ChandigarhCDSCO lab | Oct 2024 |
| Azithromycin Tablets IP 500mg AZUSTAN-500 Tablets | MGT22007BMfg 2022-01 · Exp 2023-12 | DissolutionDissolution | RDTL GuwahatiState lab | Sep 2022 |
| Amoxycillin & Potassium Clavulanate Tablets IP (DEMOXYCLAV) | MBT22020Mfg 2022-03 · Exp 2023-08 | Dissolution of Potassium ClavulanateDissolution | RDTL GuwahatiCDSCO lab | Aug 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.